BioCentury
ARTICLE | Clinical News

Bempedoic acid regulatory update

July 13, 2015 7:00 AM UTC

Esperion said FDA lifted a 2012 partial clinical hold of hypercholesterolemia candidate ETC-1002, which had prevented the company from conducting clinical trials at doses above 240 mg. The company pla...